Conférences - Pharmacologie et développement des médicaments

BDG Lifesciences (OPC) Pvt. Ltd. formerly known is BioDiscovery Group, India is a CRO and expertise in Bioinformatics. We have been conducting Workshops since 2012 and till date, we have successfully trained hundreds of participants who were not only students but scientists, faculties, professor, company executives, etc from India as well as other countries.

Tél.: [+917017955472];     Email.: workshops@biodiscoverygroup.com

drugdesign, drugdiscovery, bioinformatics, bioinfo, biotechnology, biotech, protein, proteomics, sequencealignment, itsdifferentbybiodiscovery, biodiscoverygroup, bdglifesciences, moleculardocking, admet, smallmolecule, drugtarget, pharmaceuticalchemistry, traveldubai, dubaitravel, dubainightlife, dubaidiaries, travelUAE, travelmiddleast

Biotechnologie,    Génomique et bio-informatique

On behalf of the Phytochemical Society of Europe (PSE) and the organizing committee, I am honored to invite you to participate in the Natural Products in Drug Discovery and Human Health (NatProdDDH) conference that will be held in Lisbon, Portugal, on July 28-31, 2019. During four days, the Faculty of Pharmacy of the University of Lisbon will congregate the exciting world of Natural Products research, bringing together senior scientists, young researchers, and PhD students from all over the world to share their latest advances.

Natural Products in drug discovery, Isolation and structural identification of Natural Products, Synthesis and semi-synthesis of Natural Products, Marine Natural Products, Bioactivity of Natural Products, Ethnopharmacology, Metabolomics, Phytochemical analysis, Plant Biotechnology, Cosmetics, Functional foods, Other fields related to Natural Products

Royal Society of Chemistry

The Discussion will provide a focussed meeting on mechanistic studies coupled with novel experimental and computational methods that will bring together experts with a wide range of interests and backgrounds, including those developing new physical methods for mechanistic investigations and potential end users of these methods.

This study day aims to further develop knowledge and understanding for nurses and AHPs currently administering SACT and caring for patients completing SACT in a variety of health care settings. The day will explore novel SACT and cellular therapy interventions and discuss contemporary issues and challenges regarding supportive care, late effects and SACT role and service developments.

Conference Team;     Tél.: [02078082921];     Email.: conferenceteam@rmh.nhs.uk

MEDICAL Philippines Expo 2019 co-located with Pharma Philippines 2019, Dental Philippines 2019, and Philippines Lab 2019 is the only specialized medical, dental, pharmaceutical event in the Philippines that brings together an international congregation of medical and healthcare equipment and services, dental technology, pharmaceutical companies, and its supporting industries gathered in Manila to showcase the latest developments in the medical, dental, and pharmaceutical industry.

Fireworks Exhibitions and Conferences has successfully organized international medical technology events such as Medical Myanmar, Dental Myanmar, and Medical Philippines. Fireworks Exhibitions and Conferences is the organizer of the fourth edition of medical, dental, pharmaceutical, and laboratory event in the Philippines.

Amabelle;     Tél.: [(+63) 9020-900 Ext. 115 or 226];     Email.: marcom.phil@asiafireworks.com

medical, dental, pharmaceutical, laboratory, technology, supplies, equipment

Génie biomédical,    Système de santé, gestion hospitalière

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. BioPharm America annually attracts 800+ delegates from over 500 companies who participated in 2,300+ scheduled one-to-one meetings. BioPharm America is now part of Biotech Week Boston, and together they draw a total of over 4,500 life science leaders, scientists and innovators.

Tél.: [7609300500];     Email.: conferences@ebdgroup.com

partnering, early stage, investing, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance

ASVAC 2019 aims to bring together various stakeholders in the field of vaccination to address challenges and issues relevant to clinical practice and immunization programs in the region.

Tél.: [(+65) 6389 6640];     Email.: lteopaco@kenes.com

vaccination, clinical practice and immunization

Législation en médecine et pharmacologie,    Épidémiologie

The summer school especially focuses on students and professionals who have a clear interest in learning the basics as well as latest developments in Pharmacoinformatics. The program provides an overview on main approaches and techniques used in computational drug design, ranging from protein modeling, docking, pharmacophore based screening, up to machine learning, data science, and workflows. During the afternoon sessions the participants will have the opportunity to obtain hands-on training via computational exercises. The summer school will take place at the Department of Pharmaceutical Chemistry, Universtiy of Vienna, Austria.

Email.: summerschool@europin.at

Multi‑Target Profiling and Integrated Approaches, Molecular Dynamics Simulations, Ligand- and Target-based Design, Pharmacophore Modeling, Open Data, Open Tools, Open Knowledge, Case Studies from Industry

Cours et événements pour étudiants en chimie,    Biochimie et chimie médicale, toxicologie

Cambridge Healthtech Institute

The 17th Annual Discovery on Target (DOT), the industry’s preeminent event on novel drug targets and technologies, will convene over 1,300 drug discovery professionals in Boston, MA, on September 16-19, 2019. This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules. Delegates can customize their experience at the event by choosing from 14 conference programs, plus focused training seminars, comprehensive short courses, moderated roundtables and networking functions to meet their own research needs and those of their organizations.

Cambridge Healthtech Institute;     Tél.: [7819725400];     Email.: chi@healthtech.com

PROTACs, RNA, Immune-oncology, Fibrosis, protein engineering, biotherapeutics, small molecule drugs

Over 150 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Biomanufacturing, Cell Therapy, Gene Therapy, Biologics Product Development

This conference overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. In addition to discussion of the problems, this conference addresses serialisation; track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products. It gives us immense pleasure in welcoming you to “2nd Annual Pharma Packaging, Labelling, Serialisation, Track and Trace 2019".

Tél.: [+91 44 24762472];     Email.: kavitha@virtueinsight.co.in

Healthcare, Packaging, labeling, Anticounterfeiting, Drugregulatory, Serialisation, TrackTrace, Pharmacists, Pharmaceuticals, pharma

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Federal State Institution “State Institute of Drugs and Good Practises” and the Ministry of Industry and Trade of Russian Federation

Experts from the pharmaceutical industry, representatives of government agencies, leaders of professional associations will meet on the IV all-Russian GMP conference (GMP/Good Manufacturing Practice/ system of rules and standards of production) to discuss topical issues of the Russian pharmaceutical market.

GMP/Good Manufacturing Practice/ system of rules and standards of production

American Statistical Association

Statistique, Théorie des jeux,    Législation en médecine et pharmacologie

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Oxford Global are proud to present the 17th Annual Pharmaceutical IT & Data Congress, 25 - 26 September 2019, London, UK. Over 450 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Tél.: [+44 (0)1865 248455];     Email.: a.saez@oxfordglobal.co.uk

R&D IT, Enterprise Architecture, R&D Information, Data Analytics, Enterprise Technologies, Cloud Computing, Translational Sciences, Digital Solutions, Research IT, Real-World Data, Digital Health, Real-World Evidence, Translational Informatics, Data Infrastructure, Data Management, Data Analysis, Bioinformatics, Data Standardisation, Data Storage, External Innovation, Data Archiving, Data Operations, Data Governance, Big Data, IT Strategy, Virtualisation, Blockchain, Data Validation, Data Visualisation, Knowledge Management

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Biosimilar, Biobetters, biologic, generic drug, immunogenicity, innovator, interchangeability, pharmacist, doctors, dosage, legislation, commercialising biosimilars, patent protection

Législation en médecine et pharmacologie,    Médecine translationnelle, essais cliniques

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.

Tél.: [+44 2036120886];     Email.: kavitha@virtueinsight.co.in

Pharmacovigilance, DrugSafety, ProductSafety, DrugDevelopment, ClinicalSafety, patientsafety, RiskManagement, regulatoryaffairs

SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, taking place on the 9th and 10th October 2019 in London, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Annex 1, ISO 14644, GMP, RMM, Rapid Micro Methods, Contamination recovery rates, Cleanroom, Mycoplasma, Data Integrity, Environmental monitoring, HVAC system, Contamination Control, RABS, restricted-access barrier system

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Welcome to Global Conference on Virology & Vaccines is going to be scheduled for October 14-16, 2019 in Osaka, Japan. This exciting symposium will provide you with an overview of significant areas in Virology & Vaccines research, varying from Viral Infections to T cell Activation & Gene editing. These subject areas will form the core of the scientific program that is initiated by overviews of Virus interactions with the host and is closed with an outlook on the future.

Tél.: [+0034518889990];     Email.: secretary.osaka@virologycongress.com

Immunology, Vaccines, Microbiology

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15th and 16th October 2019 in London, UK. The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Patient recruitment, Reimbursement, Patient Groups, Orphan Drugs, Gene therapy, Orphan Drugs, Rare Diseases, Gene Therapy, Clinical Trials

Biotechnologie,    Génie biomédical

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

United Scientific Group (A Non-Profit Organization) hosted three events still now on Cancer Research and Targeted Therapy twice in USA and once in UK. Having a total of 200 participants and their positive notes we are happy to announce our next event the fourth edition of Cancer Research & Drug Development at the largest independent city Baltimore USA this October 21-23, 2019.

Tél.: [+1-408-426-4832];     Email.: cancer.therapy@uniscigroup.org

Cancer Metastasis, Cancer Resistance, Cancer Microenvironment, Novel Therapeutics target in Cancer, Cancer drug development, Cancer Immunotherapy, Cancer Targeted Therapy, Cancer Nanomedicine, Cancer Radiation Therapy, Cancer Genetics, Breast Cancer, Uterine Cancer, Lung Cancer, Hematological Cancer, Sarcoma.

will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes.

Tél.: [+44 2036120886];     Email.: kavitha@virtueinsight.co.in

Pricing, Reimbursement, MarketAccess, CommercialPricing, PricingStrategists, HealthEconomics, OutcomesResearch, RegulatoryAffairs, GovernmentalAffairs, PublicAffairs

Join over 150 delegates from from internationally renowned academic institutions global pharmaceutical organisations and leading biotech companies. Over 20 presentations and case studies focusing on the discovery of stem cells in regenerative medicine, manufacturing innovations in clinical trials and bioprocessing methods in cell line development.

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Stem Cell, Stem Cell Discovery, Stem Cell Bioprocessing, Bioprocessing, cell line development, clinical trials, regenerative medicine

Over 350 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies

4 interactive streams:

- Cell Line Development

- PART 1: Early Cell Culture & Cell Line Engineering

- PART 2: 3D Cell Culture Models & Applications

- Process Development: Upstream Bioprocessing and Analytics

- Cell Line Development: Late Stage Cell Line Development, Stability, Data & Assay Data Development

- Cell Culture and Downstream Bioprocessing

View Agenda: https://bit.ly/2s1Ng0J

For further information about the congress, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk or visit the website https://bit.ly/2GF3jGh

Guillaume Alonso;     Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Cell Line Development, Cell Culture. Bioprocessing, Upstream Bioprocessing, Downstream Bioprocessing, Cell Line

Biologie moléculaire,    Cellules souches

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

ISOPT Clinical, Retina Chapter is the meeting for those who are interested in clinical research, those who wonder how drugs are developed, appreciate the opportunities and limitations of new technologies, the industry and those who would like to collaborate with it.Presentations and discussions will focus on: drugs and technologies that we own now and their best use in specific clinical situations, drugs and technologies that are in late phase development and their expected impact, defining and addressing the unmet medical needs that are still evident.

Tél.: [+972 3 517 5150 Ext. 609];     Email.: isopt@target-conferences.com

retina, Macula, Fovea, Retinal Diseases, ocular infection, Ocular Inflammation, Innovation in Ophthalmology, Ocular Drug Development, Drug delivery

Tél.: [0086-411-84799609-826];     Email.: jessica@iddst-china.com

Breaking Drug Discovery Research, Smart Screening for Hits to Leads, Emerging Drug Targets, Immunotherapy, Informatics Frontier, Preclinical Evaluation, Bioprocessing of Biotherapy, Natural Products & TCM, Smart Drug Design, Major Disease INDs

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Pharma conference 2019 will have an intensive 2-day program with a wide range of topics covering pharmacy practice, pharmaceutical science, pharmacology, pharmacovigilance, and many other pharmaceutical developments. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Tél.: [442088910774];     Email.: Pharma@pharmameet.org

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Spreadsheet Applications such as MS Excel are frequently used in 21 CFR 11 compliant environments, but they were not specifically designed for regulated environments and their development is not optimized for 21 CFR 11 compliance. However, the FDA expects that spreadsheets be compliant and lack of compliance can result in a warning letter. Consequently, validation of Excel Spreadsheet Applications is required as part of a 21 CFR 11 compliant environment.

Traininng.com LLC;     Tél.: [(510) 962-8903];     Email.: traininngdotcom@gmail.com

Learning destination for professionals courses, world class professionals trainings, professionals training courses

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

The day is aimed at medical and non-medical delegates who are new to assessing, authorising and prescribing SACT.

Conference Team;     Tél.: [02078082921];     Email.: conferenceteam@rmh.nhs.uk

Chemical biology is a scientific discipline that promises to apply the latest chemical approaches to interrogate complex biological systems and is, consequently, at the very heart of modern pharmacology. This conference will explore how recent advances in chemical biology are helping to expand the druggable proteome and enhance our understanding of disease biology .

EMBL Events;     Tél.: [+49 6221 387 8797];     Email.: events@embl.de

Drug discovery, chemical biology, genomics, DNA-sensing pathways, proteolysis targeting chimeras (PROTACs), targeted protein degradation, druggable proteome, druggable genome, phenotypic screens, chemical probes, chemogenomics, bioinformatics

The ECI “Delivery of Nucleic Acid Therapeutics: Biology, Engineering and Development” conference will provide a forum for increasing our mechanistic understanding of the biological processes underpinning non-viral and viral delivery, including molecular and cellular biology, virology, in vivo pharmacology and toxicology, rational optimization strategies, targeting, formulation, bioengineering and process development solutions to scale-up and manufacturing, regulatory considerations and preclinical and clinical NAT programs.

Tél.: [212516760];     Email.: noel@engconfintl.org

nucleic acid RNA mRNA viral drug development vectors tropism virology NAT cargo ASO's Therapeutics

The rising tide of counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores.Counterfeit drugs are not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security.We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.

Tél.: [02070960786];     Email.: info@corvusglobalevents.com

PharmaSecurityWorld, counterfeitdrugs, Anticounterfeiting, BrandProtection, drugsecuritySerialization, Traceability, SupplyChain, IP, PharmaSupplyChain, Packaging, BrandEnforcement, BrandIntegrity, Labelling, Printing, TrackAndTrace, DrugRegulatory, RFID, fakedrugs

Engineering Conferences International (ECI)

It is well known that the physical and chemical properties of the DS (API) have major impacts on the formulation and the Drug Product (DP) process. In any dosage form including solid, liquid and semi-solid, the Drug Substance (DS) or Active Pharmaceutical Ingredient (API) goes through a formulation process. This process to make the final drug product serves many purposes, but all with the goal of eventually delivering the active ingredient to the desired sites in the patients’ body in the most convenient way and to achieve optimal therapeutic effect.

Tél.: [2125146760];     Email.: noel@engconfintl.org

Role particle engineering process scaleup Pharmaceutical composite materials DS/DP interface integration DS (API)

Tél.: [+31887569555];     Email.: congress2020@ecnp.eu

brain disorder, health, neurology, pharma, mental disorder

Neurologie,    Psychiatrie